Literature DB >> 15569768

Abnormal fluid-attenuated inversion recovery signal foci in the splenium of a patient with presenilin-1 mutation.

John C Adair, Roland R Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15569768      PMCID： PMC8148752     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  4 in total

1.  A presenilin-1 mutation in a Japanese family with Alzheimer's disease and distinctive abnormalities on cranial MRI.

Authors:  M Aoki; K Abe; N Oda; M Ikeda; T Tsuda; M Kanai; M Shoji; P H St George-Hyslop; Y Itoyama
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

2.  Focal lesion in the splenium of the corpus callosum on FLAIR MR images: a common finding with aging and after brain radiation therapy.

Authors:  Joseph S Pekala; Alexander C Mamourian; Heather A Wishart; William F Hickey; James D Raque
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

3.  Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer's disease.

Authors:  Mario F Mendez; Mehdi Ghajarania; Kent M Perryman
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

4.  Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities.

Authors:  S O'Riordan; P McMonagle; J C Janssen; N C Fox; M Farrell; J Collinge; M N Rossor; M Hutchinson
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910
  4 in total
  2 in total

1.  Presenilin-1 mutation associated with amnesia, ataxia, and medial temporal lobe T2 signal changes.

Authors:  Tobias C Langheinrich; Charles A J Romanowski; Stephen Wharton; Marios Hadjivassiliou
Journal:  Neurology       Date:  2011-04-19       Impact factor: 9.910

Review 2.  Neuroimaging of rapidly progressive dementias, part 1: neurodegenerative etiologies.

Authors:  A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-22       Impact factor: 3.825
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.